BERSANO, ANNA
 Distribuzione geografica
Continente #
EU - Europa 2.907
NA - Nord America 2.419
AS - Asia 2.219
SA - Sud America 219
AF - Africa 52
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.830
Nazione #
US - Stati Uniti d'America 2.322
GB - Regno Unito 1.032
CN - Cina 813
SG - Singapore 690
IT - Italia 364
DE - Germania 335
SE - Svezia 322
RU - Federazione Russa 226
HK - Hong Kong 174
BR - Brasile 170
TR - Turchia 126
UA - Ucraina 124
IN - India 120
NL - Olanda 109
KR - Corea 108
FR - Francia 100
FI - Finlandia 81
IE - Irlanda 81
CA - Canada 77
VN - Vietnam 67
EU - Europa 61
JP - Giappone 28
CI - Costa d'Avorio 23
DK - Danimarca 22
CO - Colombia 20
ID - Indonesia 20
GR - Grecia 19
ES - Italia 18
PL - Polonia 18
BD - Bangladesh 15
AU - Australia 9
CH - Svizzera 9
AR - Argentina 8
BE - Belgio 8
SI - Slovenia 7
UZ - Uzbekistan 7
CL - Cile 6
IQ - Iraq 6
LT - Lituania 6
MX - Messico 6
MY - Malesia 6
RO - Romania 6
VE - Venezuela 6
ZA - Sudafrica 6
EG - Egitto 5
JM - Giamaica 5
LB - Libano 5
AE - Emirati Arabi Uniti 4
PH - Filippine 4
TW - Taiwan 4
CZ - Repubblica Ceca 3
EC - Ecuador 3
IL - Israele 3
KE - Kenya 3
MA - Marocco 3
NO - Norvegia 3
PE - Perù 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
AO - Angola 2
DZ - Algeria 2
KZ - Kazakistan 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
PY - Paraguay 2
SA - Arabia Saudita 2
SC - Seychelles 2
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GN - Guinea 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
MN - Mongolia 1
MR - Mauritania 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PS - Palestinian Territory 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
Totale 7.886
Città #
Southend 940
Singapore 357
Chandler 235
Ashburn 232
Hong Kong 171
Beijing 165
Seattle 163
Dallas 142
Princeton 116
Milan 106
Wilmington 104
Dublin 81
Redmond 74
Council Bluffs 72
Ann Arbor 71
Mountain View 70
Jacksonville 67
Nanjing 63
Santa Clara 61
Dearborn 55
Los Angeles 52
Bengaluru 50
Toronto 49
Woodbridge 49
Sakarya 48
Boardman 44
Jinan 43
Des Moines 41
Hefei 41
Fairfield 37
San Jose 36
Moscow 32
Buffalo 31
Frankfurt am Main 31
Shenyang 27
Abidjan 23
Hebei 23
Ho Chi Minh City 23
Shanghai 23
New York 22
Munich 21
Berlin 20
Cangzhou 20
Helsinki 20
Phoenix 20
Serra 20
Athens 19
Andover 18
Bogotá 18
Guangzhou 18
Houston 18
Ottawa 18
Somerville 18
São Paulo 17
Changsha 16
Eitensheim 15
Tianjin 15
Columbus 14
Nanchang 14
Grafing 13
Tokyo 13
Warsaw 13
Zhengzhou 13
Barcelona 12
Dong Ket 12
Fuzhou 12
The Dalles 12
Cambridge 11
Ningbo 11
Auburn Hills 10
Hanoi 10
London 10
Nuremberg 10
Rome 10
Bitonto 9
Jakarta 9
Kiez 9
Prato 9
Chicago 8
Medford 8
Redwood City 8
Taizhou 8
Brussels 7
Dhaka 7
Hangzhou 7
Istanbul 7
Lanzhou 7
Nürnberg 7
Haikou 6
Jiaxing 6
Ljubljana 6
Pune 6
Stockholm 6
Verona 6
Wuhan 6
Baghdad 5
Bergamo 5
Cairo 5
Catania 5
Chennai 5
Totale 4.758
Nome #
Clinical studies in stem cells transplantation for stroke: a review 417
A cortically blind patient with preserved visual imagery 248
Recovery after L-DOPA treatment in peg-interferon and ribavirin induced parkinsonism 213
The diagnostic challenge of Divry van Bogaert and Sneddon Syndrome : report of three cases and literature review 213
A novel efficient method to isolate human adipose-derived stromal cells from periumbilical biopsies without enzymatic digestion 211
Anti-muSK-positive myasthenia gravis in a patient with parkinsonism and cognitive impairment 194
Polymorphisms of the TNF-alphagene in italian GBS patients 193
Considerations on a mutation in the NOTCH3 gene sparing a cysteine residue: a rare polymorphism rather than a CADASIL variant 186
Transthyretin asn90 variant: amyloidogenic or non-amyloidogenic role 182
Changes in neuroimmunological pattern in IVIg treated-MMN patients : a long term follow up 180
Effect of steroid treatment in cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies 179
Stem cell therapy in stroke 178
Aphasic and visual aura with increased vasogenic leakage : an atypical migrainosus status 177
Increased levels of CSF heart-type fatty acid-binding protein and tau protein after aneurysmal subarachnoid hemorrhage 175
Role of TNF-alpha in modulating GBS phenotype in Italian patients 174
Clinical pregenetic screening for stroke monogenic diseases: results from Lombardia GENS registry 165
Aberrant splicing due to a silent nucleotide change in CCM2 gene in a family with cerebral cavernous malformation 163
Clinical and pathological aspects of an Italian patient with inclusion body myopathy and frontotemporal dementia carrying a novel mutation in valosin-containing protein gene. 162
Growth factors in ischemic stroke 160
Guillain-Barre syndrome after rtPA therapy for acute stroke 158
Clinical and pathological aspects of an Italian patient with inclusion body myopathy and frontotemporal dementia carrying a novel mutation in valosin-containing protein gene 156
Sindrome di Guillain-Barré e altre neuropatie immunomediate 154
Multifocal motor neuropathy with an unusual clinical presentation 148
How-long is IVIg effective in multifocal motor neuropathy? 145
A case-control study of anti-ganglioside and anti-Campylobacter Jejuni antibodies in Guillain-Barré syndrome in Western Lombardia 144
Long term disability and social status change after Guillain-Barré syndrome 140
Increase of Circulating Endothelial Progenitor Cells and Released Angiogenic Factors in Children with Moyamoya Arteriopathy 138
Antecedent infections in Guillain Barré syndrome (GBS) in northern Italy: a clinical and serological case-control study 130
Relazione tra i valori liquorali di Fatty Acid Binding Protein (H-FABP) e Tau con il decorso clinico e l'insorgenza di ischemia cerebrale in pazienti con emorragia subaracnoidea 127
A case control study of anti-ganglioside and anti-Campylobacter Jejuni antibodies in GBS: correlation with antecedent event and with clinical features 122
14-3-3 protein in the CSF of inflammatory neuropathies 121
Detection of CSF 14-3-3 protein in Guillain- Barré syndrome 120
Guillain-Barré syndrome : an Italian multicentre case-control study 120
14-3-3 protein in the CSF of inflammatory peripheral nervous system diseases 119
Anti-ganglioside and anti-Campylobacter Jejuni (CJ) antibodies in Guillain-Barré syndrome (GBS): regional and temporal variability in Italian patients 119
Multifocal motor neuropathy: clinical and immunological features and response to IVIg therapy in patients with definite, probable or no overt conduction block 118
Is campylobacter jejuni enteritis a risk factor for Guillain Barré sindrome in Italy? A case control study by western blot in northern Italy 118
Fatty acid binding protein and Tau levels are related to brain damage after subarachnoid hemorrhage 117
A case Control study of anti-ganglioside and anti-Campylobacter jejuni antibnodies in Guillain Barré syndrome in western Lombardia 113
Long-term effect of intravenous immunoglobulin therapy (IVIg) in multifocal motor neuropathy (MMN) 112
Anti-ganglioside and anti-Campylobacter Jejuni antibodies in Guillain Barré syndrome: A case control study 112
Long-term effect of IVIg in multifocal motor neuropathy 111
Treatment of multifocal motor neuropathy 110
Proteome Profiling of the Dura Mater in Patients with Moyamoya Angiopathy 108
14-3-3 protein in the CSF of dysimmune neuropathies 108
Heart-fatty acid-binding and tau proteins relate to brain injury severity and long-term outcome in subarachnoid haemorrhage patients 108
Pain: a frequent and often overlooked presenting symptom in Guillain Barré syndrome 106
High-dose intravenous immunoglobulin therapy in dysimmune neuropathies 105
Risk factors for Guillain Barré sindrome (GBS) in northern Italy: analysis of anamnestic antecedent events and serological evidence of infections 102
Clinical and immunological features and response to IVIg in patients with clinically typical multifocal motor neuropathy but no overt conduction block 99
Residual disability and psychosocial status after Guillain Barré syndrome: a 3 to 5 year follow-up study 95
Effect of Migalastat on cArdiac InvOlvement in FabRry DiseAse: MAIORA study 94
Long-term prognosis of post-attinic radiculoplexopathy under immunododulating therapies 87
Frequently delayed increase of anti-ganglioside antibodies in Guillain-Barré syndrome 83
CSF and Plasma Biomarkers in Patients With Iatrogenic Cerebral Amyloid Angiopathy 78
Multifocal motor neuropathy: comparison of clinical and immunological features and response to IVIg therapy in patients with and without overt conduction block 77
Postirradiation lumbosacral radiculoplexopathy: improvemenet after immune therapy 72
Improvement of postirradiation lumbosacral radiculoplexopathy after immune therapy 70
null 3
Impact of cardiac magnetic resonance on the clinical management of patients with Fabry disease: Data from the CMR Italian research and CLinical nEtwork for Fabry disease (CIRCLE-FD) 1
Totale 8.238
Categoria #
all - tutte 21.279
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.279


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021402 0 0 0 0 0 0 35 48 68 30 177 44
2021/2022517 46 10 14 18 30 57 33 16 60 46 76 111
2022/2023768 106 89 71 99 76 151 16 36 74 8 25 17
2023/2024459 15 40 33 16 124 19 20 40 10 37 43 62
2024/20251.255 47 95 30 133 115 33 85 117 58 108 127 307
2025/20261.403 278 169 251 194 286 176 49 0 0 0 0 0
Totale 8.238